Heath - Applied Sciences
Covid 19 Report
Bloomberg adjusted highlights
LVMH Moet Hennessy Louis Vuitton SE (MC FP) - BBG Adj Highlights
In Millions of GBP FY 2014 FY 2015 FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 Current/LTM FY 2021 Est FY 2022 Est
12 Months Ending 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 06/30/2021 12/31/2021 12/31/2022
Market Capitalization 51,542.90 53,729.40 77,804.40 109,675.10 116,664.90 176,620.20 230,547.90 264,926.90
ERROR:#NAME? 3,823.90 3,357.70 3,347.40 3,780.70 4,740.40 5,423.60 18,551.10 7,470.00
ERROR:#NAME? 963 1,076.70 1,290.10 1,251.60 1,495.10 1,506.20 1,269.00 1,237.30
+ Total Debt 7,178.00 6,106.30 6,304.30 10,290.30 9,912.00 21,383.60 33,610.50 33,083.60
Enterprise Value 55,859.90 57,554.70 82,051.30 117,436.40 123,331.60 194,086.40 246,876.20 291,795.20
Revenue, Adj 24,701.70 25,905.10 30,802.40 37,366.70 41,435.60 47,085.10 39,711.80 48,664.60 51,871.60 57,738.10
Growth %, YoY 5.6 16.4 5.4 13.4 9.8 14.6 -16.8 18 30.6 11.3
Gross Profit, Adj 15,993.40 16,787.00 20,120.70 24,410.70 27,609.30 31,185.70 25,596.40 34,887.30 38,997.50
Margin % 64.7 64.8 65.3 65.3 66.6 66.2 64.5 67.3 67.5
EBITDA, Adj 6,120.20 6,318.70 7,491.70 9,323.30 10,869.90 14,558.90 12,973.40 16,568.80 18,452.20
Margin % 24.8 24.4 24.3 25 26.2 30.9 32.7 31.9 32
Net Income, Adj 2,995.60 2,667.90 3,412.40 4,801.20 5,727.30 6,437.10 4,498.10 8,617.10 9,723.80
Margin % 12.1 10.3 11.1 12.8 13.8 13.7 11.3 16.6 16.8
EPS, Adj 5.95 5.29 6.76 9.52 11.37 12.77 8.92 16.99 18.99
Growth %, YoY 0.7 -11.1 28 40.8 19.4 12.4 -30.2 90.6 11.7
Cash from Operations 3,770.00 4,095.20 5,104.50 6,121.70 7,528.60 10,218.00 9,702.30
Capital Expenditures -1,235.20 -1,263.10 -1,761.30 -1,655.50 -2,304.20 -2,889.90 -2,203.90 -2,825.40 -3,008.20
Free Cash Flow 2,534.80 2,832.10 3,343.20 4,466.20 5,224.40 7,328.20 7,498.40 7,428.70 10,364.00
Source: Bloomberg Right click to show data transparency (not supported for all values)
Company model
MC FP Equity- Company Financial (Multiple Periods)
MC FP Equity Periodicity:A Currency:GBP Estimate Source:BST Actual Source:Bloomberg
In Millions of GBP 2011 A (Rep) 2012 A (Rep) 2013 A (Rep) 2014 A (Rep) 2015 A (Rep) 2016 A (Rep) 2017 A (Rep) 2018 A (Rep) 2019 A (Rep) 2020 A (Rep) 2021 A (Fwd) 2022 A (Fwd) 2023 A (Fwd) 2024 A (Fwd) 2025 A (Fwd) 2026 A (Fwd) 2027 A (Fwd)
12 Months Ending 12/31/2011 12/31/2012 12/31/2013 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025 12/31/2026 12/31/2027
Highlights
Non-IFRS Diluted EPS 5.33 5.47 5.75 8.97 5.11 6.43 8.92 11.16 12.48 8.28 16.99 18.98 21.11 21.7 23 25.87 26.78
Revenue 20,535.64 22,798.15 24,750.98 24,701.62 25,905.24 30,802.41 37,366.75 41,435.67 47,085.11 39,711.83 51,871.58 57,738.11 62,383.70 65,378.31 69,686.34 74,682.16 78,962.64
Organic Revenue Growth (%) 14 9 4 5 6 6 12 11 10 -16 28.66 10.68 8.94 7.17 7.28 7.14 7.18
Revenue
Wines & Spirits 3,960.89 4,455.68 4,550.97 4,891.87 4,229.01 5,031.38 5,409.14 5,801.52 6,113.55 6,457.10 6,812.95 7,545.79
Fashion & Leather Goods 10,465.45 13,559.86 16,330.57 19,508.69 18,861.14 23,244.36 25,624.50 30,716.43 32,198.05 34,463.41 36,684.75 39,372.18
Perfume & Cosmetics 4,057.56 4,872.86 5,390.73 5,996.40 4,667.48 5,483.56 5,962.25 6,526.88 6,947.22 7,381.77 7,301.24 7,713.67
Watches & Jewelry 2,841.03 3,334.75 3,648.39 3,864.54 2,984.77 6,550.53 7,215.47 7,875.54 8,920.57 9,594.08 10,186.98 10,613.09
Selective Retailing 9,808.44 11,665.94 12,075.15 12,976.26 9,031.68 10,070.93 11,275.98 12,440.97 12,702.03 13,667.84 14,997.50 17,787.35
Operating Income
Wines & Spirits 1,232.10 1,365.45 1,441.48 1,516.87 1,234.46 1,466.22 1,730.79 1,861.90 1,976.15 2,097.80 2,205.09 2,339.19
Fashion & Leather Goods 3,172.81 4,298.81 5,258.88 6,442.95 6,392.88 9,580.36 10,369.53 11,619.97 12,264.75 12,920.97 13,311.13 13,446.12
Perfume & Cosmetics 451.39 525.85 598.18 599.2 71.15 523.38 641.59 756.96 788.46 842.35 920.54 1,018.36
Watches & Jewelry 375.2 448.72 622.07 645.7 268.59 1,070.02 1,229.07 1,385.65 1,539.99 1,671.17 1,496.07 1,476.06
Selective Retailing 752.86 942.14 1,222.91 1,223.84 -180.54 436.85 814.11 975.77 1,077.67 1,206.90 1,508.61 1,735.93
Non-IFRS Operating Income 4,568.20 4,803.32 5,112.55 4,607.67 4,797.67 5,755.79 7,268.09 8,851.51 10,092.55 7,386.32 13,054.78 14,710.33 16,380.70 17,302.16 18,413.42 20,695.56 19,796.42
Non-IFRS Net Income 2,660.37 2,777.67 2,917.57 4,553.65 2,595.32 3,261.29 4,495.12 5,622.57 6,291.17 4,181.88 8,617.08 9,723.79 10,676.22 11,129.07 11,790.98 12,977.12 13,369.10
Dividend Per Share 2.26 2.35 2.63 2.58 2.58 3.28 4.38 5.31 4.21 5.34 6.48 7.34 8.32 9.52 10.95 11.51 14.52
Company Operating Metrics
Company-Level Industry Statistics
Organic Revenue Growth (%) 14 9 4 5 6 6 12 11 10 -16 28.66 10.68 8.94 7.17 7.28 7.14 7.18
By Segment
Wines & Spirits 7 7 5 6 -14 25.46 7.24 6.22 5.83 5.81 6.34 6.35
Champagne & Wines 6 7 3 3 -16 27.48 4.8 4.33 4.17 4.17
Cognac & Spirits 8 7 7 7 -12 21.64 6.74 6.69 6.7 6.72
Fashion & Leather Goods 4 13 15 17 -3 37.02 11.38 8.63 7.66 7.75 7.29 7.33
Perfume & Cosmetics 8 14 14 9 -22 24.64 8.71 8.02 7.14 7.17 7.13 7.12
Watches & Jewelry 5 12 12 3 -23 42.42 9.59 7.51 6.61 6.49 6.6 6.76
Selective Retailing 8 13 6 5 -30 14.84 12.12 8.63 6.5 6.74 7.21 7.21
By Region
Europe 7 10 7 11 -28 21.58 8.34 6.66 5.8 5.81 6.05 6.05
Asia (Excl. Japan) 5 17 15 14 -4 35.33 10.57 7.2 6.35 6.36
Japan -3 12 15 8 -19 12.92 5.18 2.92 2.92 2.93 2.14 2.14
United States 7 9 8 6 -13 29.8 7.09 6.42 6.04 6.12 6.56 6.63
Balance Sheet & Cash Flow Metrics
Inventories As % of Revenue 28.52 28.09 28.82 28.42 27.93 26.28 24.37 24.89 29.2 23.7 25.4 24.83 24.19 24.49 24.42 22.33 22.2
Business Breakdown
Wines & Spirits
Revenue 3,960.89 4,455.68 4,550.97 4,891.87 4,229.01 5,031.38 5,409.14 5,801.52 6,113.55 6,457.10 6,812.95 7,545.79
Non-IFRS Operating Income 1,232.10 1,365.45 1,441.48 1,516.87 1,234.46 1,466.22 1,730.79 1,861.90 1,976.15 2,097.80 2,205.09 2,339.19
Operating Margin (%) 31.1 30.6 31.7 31 29.2 32.27 31.94 32.09 32.3 32.58 32.28 31
Champagne & Wines
Revenue 1,874.36 2,108.65 2,096.29 2,199.41 1,884.60 2,321.75 2,464.07 2,594.21 2,717.43 2,846.54 3,126.82 3,417.52
Operating Income 590.7 574.29 605.34 434.02 665.21 696.19 733.83 774.9 812.07 897.2 956.91
Cognac & Spirits
Revenue 2,086.54 2,347.91 2,454.67 2,692.46 2,344.41 2,776.32 2,983.05 3,184.95 3,395.49 3,620.19 3,686.13 4,128.27
Non-IFRS Operating Income 774.75 867.19 911.52 800.44 990.97 1,059.69 1,125.18 1,203.45 1,285.72 1,307.89 1,382.29
Fashion & Leather Goods
Revenue 10,465.45 13,559.86 16,330.57 19,508.69 18,861.14 23,244.36 25,624.50 30,716.43 32,198.05 34,463.41 36,684.75 39,372.18
Non-IFRS Operating Income 3,172.81 4,298.81 5,258.88 6,442.95 6,392.88 9,580.36 10,369.53 11,619.97 12,264.75 12,920.97 13,311.13 13,446.12
Operating Margin (%) 30.3 31.7 32.2 33 33.9 38.83 38.17 38.74 38.57 38.11 37.77 36.65
Perfume & Cosmetics
Revenue 4,057.56 4,872.86 5,390.73 5,996.40 4,667.48 5,483.56 5,962.25 6,526.88 6,947.22 7,381.77 7,301.24 7,713.67
Non-IFRS Operating Income 451.39 525.85 598.18 599.2 71.15 523.38 641.59 756.96 788.46 842.35 920.54 1,018.36
Operating Margin (%) 11.1 10.8 11.1 10 1.5 11.16 11.12 11.43 11.17 11.19 11.75 12.28
Watches & Jewelry
Revenue 2,841.03 3,334.75 3,648.39 3,864.54 2,984.77 6,550.53 7,215.47 7,875.54 8,920.57 9,594.08 10,186.98 10,613.09
Non-IFRS Operating Income 375.2 448.72 622.07 645.7 268.59 1,070.02 1,229.07 1,385.65 1,539.99 1,671.17 1,496.07 1,476.06
Operating Margin (%) 13.2 13.5 17.1 16.7 9 18.03 18.15 18.78 18.71 19.28 18.68 20.4
Selective Retailing
Revenue 9,808.44 11,665.94 12,075.15 12,976.26 9,031.68 10,070.93 11,275.98 12,440.97 12,702.03 13,667.84 14,997.50 17,787.35
Non-IFRS Operating Income 752.86 942.14 1,222.91 1,223.84 -180.54 436.85 814.11 975.77 1,077.67 1,206.90 1,508.61 1,735.93
Operating Margin (%) 7.7 8.1 10.1 9.4 -2 4.31 7.23 7.84 8.43 8.79 10.1 9.76
Holding Companies & Other
Revenue -330.96 -522.34 -560.13 -152.65 -62.26 -76.81 -84.59 -88.95 -77.43 -83.45 -99.21
Non-IFRS Operating Income -228.56 -312.88 -292.01 -336.01 -400.22 -340.5 -346.04 -422.36 -467.48 -504.31 -500.63 -656.55
Regional Breakdown
Total Revenue 20,535.64 22,798.15 24,750.98 24,701.62 25,905.24 30,802.41 37,366.75 41,435.67 47,085.11 39,711.83 51,871.58 57,738.11 62,383.70 65,378.31 69,686.34 74,682.16 78,962.64
Europe (Excluding France) 5,591.13 7,099.68 7,872.78 8,946.17 6,353.89 7,667.23 8,384.00 10,146.63 10,786.56 11,468.08 12,161.48 12,897.79
France 3,067.95 3,736.68 4,143.57 4,237.66 3,176.95 3,925.08 4,332.71 5,394.42 5,689.20 6,000.52 6,329.29 6,676.41
Asia (Excluding Japan) 8,128.23 10,463.46 12,016.35 14,125.53 13,502.02 18,021.09 20,032.09 23,655.27 25,565.37 27,581.70 29,757.23 32,104.55
United States 8,195.41 9,340.92 9,944.56 11,300.43 9,530.84 11,886.75 12,753.53 14,825.24 15,748.34 16,755.53 17,854.13 19,038.71
Japan 2,208.60 2,615.67 2,900.50 3,295.96 2,779.83 3,377.03 3,604.84 3,799.56 4,005.19 4,225.16 3,463.36 3,537.45
Other Markets 3,611.09 4,110.34 4,557.92 5,179.36 4,368.30 4,866.93 5,381.67 6,229.22 6,883.69 7,577.28 8,328.39 9,149.68
Income Statement
Total Revenue 20,535.64 22,798.15 24,750.98 24,701.62 25,905.24 30,802.41 37,366.75 41,435.67 47,085.11 39,711.83 51,871.58 57,738.11 62,383.70 65,378.31 69,686.34 74,682.16 78,962.64
Cost of Revenue 7,023.73 8,045.02 8,488.65 8,708.21 9,118.11 10,681.72 12,956.02 13,826.34 15,899.45 14,115.39 17,035.06 18,680.77 20,415.23 21,625.45 23,203.59 24,237.44 25,520.97
As % Revenue 34.2 35.29 34.45 35.25 35.2 34.68 34.67 33.37 33.77 35.54 32.68 32.48 32.43 32.6 32.95 33 33.09
Gross Profit 20,120.69 24,410.74 27,609.33 31,185.66 25,596.44 34,709.05 38,616.41 42,399.97 44,629.73 47,436.14 49,253.15 51,673.89
Gross Margin (%) 65.8 64.71 65.51 64.75 64.8 65.32 65.33 66.63 66.23 64.46 67.26 67.54 67.5 67.36 67.15 67 66.91
Total Operating Expenses
Advertising 2,353.11 2,658.42 2,810.59 2,808.94 2,917.83 3,475.10 4,233.95 4,882.80 5,496.33 4,330.40 5,789.24 6,430.82 6,906.75 7,318.66 7,798.94 7,981.15 8,451.72
Selling & Marketing 10,045.69 11,966.24 14,368.79 15,711.15 17,727.76 14,934.52 17,909.93 19,976.47 21,905.96 22,879.41 24,332.84 25,165.35 26,695.49
General & Administrative 1,934.32 2,401.11 2,771.22 3,067.01 3,389.92 3,238.24 3,744.52 4,069.51 4,470.10 4,816.21 5,156.67 6,201.33 6,783.67
Operating Income 4,473.59 4,655.68 5,008.11 4,378.70 4,637.14 5,655.85 7,110.34 8,740.02 9,889.89 7,090.16 12,619.67 13,963.43 15,588.12 17,129.92 18,213.38 19,075.50 19,612.37
Operating Margin (%) 21.78 20.42 20.41 17.74 17.94 18.35 19.04 21.04 20.95 17.95 24.52 24.75 25.37 26.11 25.93 25.88 25.28
EBITDA 5,335.50 5,711.91 6,129.79 5,859.76 6,031.77 7,194.33 9,349.58 10,888.52 12,461.28 10,479.60 16,568.78 18,452.15 20,433.93 19,158.87 21,317.52 23,405.13
Interest Income (Expense), Net 260.51 51.71 343.34 490.42 540.74 418.74 476.79 427.25 402.2 375.8 436.19 681.48
Cost of Net Financial Debt 108.96 120.07 103.53 93.87 31.13 167.59 167.38 81.68 52.68 34.18 -30.92 -49.1
Interest on Lease Liabilities 254.42 249.92 246.16 257.09 262.69 268.2 273.7 360.22 385.44
Income (Loss) from Affiliates -19.53 -4.03 -9.44 2.46 -2.63 20.35 24.56 -37.35 8.4 16.63 18.31 18.17 13.06 27.69 29.07
Pre-Tax Income 4,263.54 4,644.32 4,835.74 6,754.69 4,336.43 5,301.95 6,953.46 8,396.68 9,399.48 6,549.41 12,759.05 14,265.82 15,837.77 16,464.23 17,846.57 18,685.28 19,122.15
Income Tax Expense 1,261.18 1,476.45 1,488.51 1,832.59 1,430.22 1,747.38 1,940.38 2,211.33 2,572.27 2,142.52 3,371.97 3,733.69 4,142.88 4,670.05 4,918.66 5,138.61 5,171.98
Tax Rate (%) 29.58 31.79 30.75 27.13 32.98 32.39 27.49 26.34 27.37 32.71 27.73 27.79 27.89 27.89 27.59 27.57 27.21
Net Income before Minority Interest 3,007.57 3,171.12 3,351.47 4,922.10 2,906.20 3,647.96 5,118.25 6,185.35 6,827.21 4,406.89 8,997.36 9,936.40 11,187.37 12,176.75 12,960.34 14,395.02
Minority Interest 347.19 393.45 433.9 368.45 310.89 317.04 416.3 562.79 536.04 225.01 483.23 541.49 624.16 599.29 662.23 569.71 581.43
Net Income 2,660.37 2,777.67 2,917.57 4,553.65 2,595.32 3,261.29 4,495.12 5,622.57 6,291.17 4,181.88 8,475.75 9,481.05 10,459.81 11,005.27 11,679.38 12,977.12 13,369.10
Basic Weighted Avg. Shares 488.77 499.13 500.28 501.31 502.4 502.91 502.41 502.83 503.22 503.68 503.46 501.96 501.16 500.32 498.64
Diluted Weighted Avg. Shares 492.21 502.23 503.22 503.86 504.89 504.64 504.01 503.92 503.84 504.21 503.82 503.07 502.81 502.66 502.12 501.81 498.43
Basic EPS 5.44 5.57 5.83 9.09 5.16 6.62 9.36 11.18 12.5 8.3 16.55 17.36 19.48 20.77 22.42 22.2 23.33
Diluted EPS 5.33 5.47 5.75 8.97 5.11 6.43 8.92 11.16 12.48 8.28 16.77 18.76 20.82 20.71 20.84 24.74 23.33
Dividend Per Share 2.26 2.35 2.63 2.58 2.58 3.28 4.38 5.31 4.21 5.34 6.48 7.34 8.32 9.52 10.95 11.51 14.52
Dividend Payout Ratio 42.26 42.35 45.06 28.43 49.96 49.39 46.86 47.49 33.71 64.3 36.24 36.64 35.96 36.72 37.32 51.75 62.11
Non-IFRS Results
Operating Income 4,568.20 4,803.32 5,112.55 4,607.67 4,797.67 5,755.79 7,268.09 8,851.51 10,092.55 7,386.32 13,054.78 14,710.33 16,380.70 17,302.16 18,413.42 20,695.56 19,796.42
Operating Margin (%) 22.25 21.07 20.74 18.65 18.52 18.69 19.45 21.36 21.43 18.6 25.42 25.58 26.06 26.43 26.35 27.2 27.21
EBITDA, incl IFRS 16 16,660.25 18,370.17 20,241.62 22,198.90 23,417.53 27,444.60 29,523.73
Net Income 2,660.37 2,777.67 2,917.57 4,553.65 2,595.32 3,261.29 4,495.12 5,622.57 6,291.17 4,181.88 8,617.08 9,723.79 10,676.22 11,129.07 11,790.98 12,977.12 13,369.10
Diluted EPS 5.33 5.47 5.75 8.97 5.11 6.43 8.92 11.16 12.48 8.28 16.99 18.98 21.11 21.7 23 25.87 26.78
Company Specific Adjustments
Operating Lease Expenses 1,356.66 1,577.04 2,098.17 2,210.71 2,460.94 2,803.35 3,315.47 3,254.61 1,729.17 956.09 4,134.73 4,577.50 4,949.64 5,338.95 5,759.12
Condensed Balance Sheet
Assets
Current Assets 11,086.49 11,597.14 13,293.74 14,063.99 13,975.21 16,571.90 18,721.93 21,160.05 22,444.45 35,797.37 35,438.42 41,672.05 47,383.34 55,630.00 62,900.76 72,571.06 69,012.85
Cash & Cash Equivalents 1,924.49 1,784.30 2,685.22 3,177.02 2,650.50 3,027.83 3,322.85 4,141.98 4,802.99 17,877.64 12,535.84 17,847.47 23,292.23 29,120.63 33,763.06 48,236.48 41,222.05
Accounts Receivables 1,569.34 1,612.86 1,809.57 1,765.96 1,859.18 2,293.94 2,432.13 2,894.90 2,920.91 2,468.10 3,176.19 3,433.30 3,766.17 3,924.57 4,132.54 3,935.65 3,709.07
Inventories 6,275.69 6,565.19 7,068.46 7,358.16 7,445.58 9,010.02 9,678.76 11,217.50 11,613.38 11,656.33 13,643.73 14,658.67 15,701.86 16,724.48 18,254.36 19,185.36 18,872.23
Financial Fixed Assets 142.06 132.44 399.54 403.05 537.62 657.85 568.03 573.23 909.29 886.58 794.06 797.89 840.99 839.62 838.93 845.67 845.67
Non-Current Assets 28,246.43 29,027.39 33,465.34 27,376.24 28,504.26 34,361.26 43,285.96 45,596.86 59,262.33 61,521.72 71,504.04 72,077.60 72,693.08 73,255.18 73,735.84 81,691.73 84,016.48
Intangible Assets 15,408.44 15,694.70 18,024.09 16,961.43 17,473.80 20,278.95 27,373.96 27,835.75 28,147.43 29,601.14 38,958.08 39,030.12 39,355.73 41,194.32 42,016.72 39,633.08 39,976.42
Goodwill 5,813.57 6,342.56 7,539.58 6,841.73 7,464.75 8,886.14 12,300.24 12,333.41 13,575.04 14,366.23 17,840.98 17,840.98 18,305.07 18,114.78 18,744.88 19,476.64 22,377.61
Right of Use Assets 10,505.12 11,213.04 11,231.00 11,507.28 11,631.94 12,128.46 11,311.60 11,895.02 12,820.97
Other Intangible Assets 9,594.86 9,352.14 10,484.50 10,119.70 10,009.05 11,392.81 15,073.72 15,502.34 14,572.39 15,234.91 16,052.91 15,028.60 15,226.91 15,189.23 15,388.54 14,866.79 15,987.91
Total Assets 39,332.92 40,624.53 46,759.08 41,440.23 42,479.47 50,933.17 62,007.88 66,756.91 81,706.79 97,319.10 104,125.37 110,755.99 118,136.03 125,705.23 132,318.54 143,863.79 148,321.65
Liabilities & Equity
Current Liabilities 8,017.17 7,704.34 9,687.93 9,454.95 9,365.23 10,944.27 13,324.29 15,124.08 19,153.56 22,673.25 21,220.62 22,053.84 24,602.44 25,318.18 27,047.20 28,870.50 26,652.69
Accounts Payables 2,466.82 2,546.45 2,744.32 2,800.37 2,920.41 3,574.62 4,034.89 4,774.51 4,922.37 4,565.46 5,259.03 5,718.20 6,469.62 6,846.19 7,291.66 6,732.07 6,001.43
Current Lease Liabilities 1,838.90 1,937.05 1,895.10 1,913.58 1,932.98 1,953.35 2,006.48 2,358.13 2,476.03
Other Short-Term Liabilities 2,931.44 2,739.83 3,053.12 3,401.45 3,665.27 4,424.70 5,262.51 5,832.92 5,948.50 6,644.00 8,699.91 9,531.85 10,348.64 11,314.15 12,082.65
Non-Current Liabilities 11,668.09 12,194.35 13,842.27 14,121.46 14,088.04 16,154.13 21,680.31 21,123.22 30,071.84 39,872.97 39,521.96 40,150.60 40,247.63 40,659.44 39,643.53 42,318.53 48,374.33
Long-Term Debt 3,452.88 3,116.84 3,453.49 3,924.87 3,230.15 3,359.32 6,263.46 5,025.19 4,318.72 12,595.75 12,146.16 12,145.56 11,270.96 11,414.87 11,111.09 12,014.45 12,014.45
Non Current Lease Liabilities 8,782.21 9,550.92 9,111.03 9,111.32 9,111.62 9,111.92 9,112.22 9,115.52 9,116.42
Deferred Taxes Liabilities 3,279.90 3,217.59 3,562.53 3,410.77 3,455.08 3,534.46 4,434.91 4,524.73 4,654.83 4,908.45 4,683.29 4,683.29 4,683.29 4,683.29 4,683.44 4,672.17 4,672.17
Total Liabilities 19,685.26 19,898.69 23,530.20 23,576.40 23,453.27 27,098.40 35,004.61 36,247.30 49,225.40 62,546.22 65,266.64 65,933.34 67,325.26 68,313.87 69,023.99 74,254.29 79,796.63
Total Shareholder Equity 19,647.66 20,725.84 23,228.88 17,863.83 19,026.19 23,834.77 27,003.28 30,509.62 32,481.38 34,772.88 39,542.34 45,071.45 51,717.40 58,828.81 65,155.24 65,210.88 70,655.75
Non-Controlling Interests 886.62 880.78 855.67 962.97 1,076.72 1,290.07 1,251.62 1,495.07 1,506.17 1,268.98 1,406.84 1,634.93 1,975.24 2,007.73 2,423.68 1,397.53 1,432.48
Total Liabilities & Shareholder Equity 39,332.92 40,624.53 46,759.08 41,440.23 42,479.47 50,933.17 62,007.88 66,756.91 81,706.79 97,319.10 104,125.37 110,755.99 118,136.03 125,705.23 132,318.54 143,863.79 148,321.65
Special Company Reference Items
Book Value Per Share 38.12 39.51 44.46 33.54 35.55 44.67 51.09 57.58 61.48 66.45 74.06 86.07 99.15 116.89 133.11
ROE 15.46 14.61 13.39 23.22 15.5 16.03 19.38 20.74 20.82 12.71 23.46 21.73 21.26 20.48 19.73 18.99 18.7
Condensed Cash Flow Statement
Cash from Operating Activities
Net Income 2,660.37 2,777.67 2,917.57 4,553.65 2,595.32 3,261.29 4,495.12 5,622.57 6,291.17 4,181.88 8,475.75 9,481.05 10,459.81 11,005.27 11,679.38 12,977.12 13,369.10
Depreciation & Amortization 867.12 1,053.79 1,218.49 1,527.83 1,511.57 1,755.57 2,082.36 2,037.01 4,481.29 5,380.77 4,463.98 4,830.64 5,236.59 4,834.66 5,163.05
Change in Working Capital -463.5 -659.53 -526.45 -578.88 -311.61 -419.44 -450.48 -961.87 -1,021.19 -325.51 -2,226.60 -648.69 -603.54 -726.77 -784.71 -682.8 -1,121.94
Lease Liabilities: Interest Paid 209.68 257.92 245.93 272.54 285.83 298.84 311.78 335.46 358.94
Cash Flow from Operations 5,059.46 6,110.35 7,512.68 10,218.88 9,691.60 12,419.51 14,870.97 16,392.63 16,906.81 18,134.46 20,907.83 22,490.18
Cash from Investing Activities
Capital Expenditures -1,518.10 -1,501.60 -1,557.29 -1,489.93 -1,492.69 -2,121.76 -2,055.19 -2,779.43 -2,889.85 -2,203.89 -2,797.63 -2,974.71 -3,300.06 -3,471.46 -3,721.52 -3,820.51 -4,168.15
Cash Flow from Investing -1,882.55 -7,543.29 -3,043.12 -5,148.92 -2,613.90 -12,178.31 -2,792.25 -3,061.73 -3,271.19 -3,418.80 -3,667.03 -3,479.70
Cash from Financing Activities
Dividends Paid -927.88 -1,173.86 -1,274.53 -1,305.30 -1,213.76 -1,522.92 -1,849.23 -2,402.47 -3,226.74 -2,164.76 -2,611.76 -3,022.24 -3,693.50 -4,390.28 -4,985.35 -4,705.97
Lease Liabilities: Repayment 1,918.67 2,047.36 2,085.33 2,134.69 2,194.40 2,258.17 2,448.65 3,297.14 3,527.94
Other -218.73 -227.87 -299.98 -324.62 -338.51 -431.81 -488.66 -533.35 -581.15 -602.91 -677.76
Special Company Reference Items
Net Change in Cash 33.85 -75.44 793.93 699.01 -285.46 -43.42 246.27 703.48 951 12,726.18 -4,904.25 5,917.11 6,599.53 5,040.32 3,237.73 2,515.50 1,888.98
Net Debt 3,123.22 2,771.52 6,358.57 5,176.13 5,254.25 3,797.98 8,285.88 1,165.52 -7,109.55 -15,847.59 -24,695.75
Free Cash Flow 2,007.00 2,595.76 2,283.28 2,672.31 3,203.94 4,115.64 4,824.40 5,410.36 5,440.35 7,575.11 9,362.53 9,765.38 10,554.30 11,014.16 13,112.16 14,173.90
Source: Bloomberg
Earnings
LVMH Moet Hennessy Louis Vuitton SE (MC FP) - Earnings
In Millions of GBP except Per Share FY 2011 FY 2012 FY 2013 FY 2014 FY 2015 FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 Est FY 2022 Est FY 2023 Est FY 2024 Est FY 2025 Est
12 Months Ending 12/31/2011 12/31/2012 12/31/2013 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Revenue
Consensus Estimate 19,522.60 22,905.50 24,599.50 23,789.60 26,129.30 31,931.80 37,612.20 42,139.00 45,803.30 40,683.20 51,871.60 57,738.10 62,383.70 65,378.30 69,686.30
Comparable Actual 20,535.60 22,798.10 24,751.00 24,701.70 25,905.10 30,802.40 37,366.70 41,435.60 47,085.10 39,711.80
Revenue Surprise % 5.2 -0.5 0.6 3.8 -0.9 -3.5 -0.7 -1.7 2.8 -2.4
GAAP Actual 20,535.60 22,798.10 24,638.10 24,701.70 25,905.10 30,802.40 37,366.70 41,435.60 47,085.10 39,711.80
Adjusted Actual 20,535.60 22,798.10 24,638.10 24,701.70 25,905.10 30,802.40 37,366.70 41,435.60 47,085.10 39,711.80
Earnings Per Share
Consensus Estimate 5.19 5.9 5.89 5.32 5.41 6.83 8.65 11.47 12.47 7.24 16.99 18.99 21.11 21.7 23
Comparable Actual 5.33 5.47 5.75 8.97 5.11 6.43 8.92 11.16 12.48 8.28
EPS Surprise % 2.7 -7.3 -2.5 68.4 -5.6 -5.8 3.2 -2.7 0.1 14.4
GAAP Actual 5.41 5.53 5.8 9.04 5.14 6.6 9.33 11.16 12.48 8.29
Adjusted Actual 5.53 5.58 5.9 5.95 5.29 6.76 9.52 11.37 12.77 8.92
EBIT
Consensus Estimate 4,273.80 4,837.40 5,060.40 4,553.80 4,806.50 5,877.30 7,340.30 8,975.70 9,777.40 6,674.00 13,054.80 14,710.30 16,380.70 17,302.20 18,413.40
Comparable Actual 4,568.20 4,803.30 5,112.60 4,607.70 4,797.60 5,755.80 7,268.10 8,851.50 10,092.60 7,386.30
EBIT Surprise % 6.9 -0.7 1 1.2 -0.2 -2.1 -1 -1.4 3.2 10.7
GAAP Actual 4,473.60 4,655.70 5,027.60 4,382.70 4,646.60 5,653.40 7,113.00 8,719.70 9,865.30 7,127.50
Adjusted Actual 4,538.70 4,710.00 5,102.40 4,592.40 4,807.10 5,736.10 7,240.90 8,832.90 10,077.60 7,592.70
EBITDA
Consensus Estimate 4,943.90 5,742.40 6,046.40 5,638.70 6,044.90 7,362.40 9,056.60 11,023.50 12,271.70 9,808.40 16,568.80 18,452.20 20,433.90 19,158.90 21,317.50
Comparable Actual 5,335.50 5,711.90 6,129.80 5,859.80 6,031.70 7,194.30 9,349.60 10,888.50 12,461.30 10,479.60
EBITDA Surprise % 7.9 -0.5 1.4 3.9 -0.2 -2.3 3.2 -1.2 1.5 6.8
GAAP Actual 5,340.70 5,709.50 6,246.10 5,910.60 6,158.10 7,409.00 9,195.30 10,756.70 14,346.60 12,508.30
Adjusted Actual 5,405.80 5,763.80 6,320.80 6,120.20 6,318.70 7,491.70 9,323.30 10,869.90 14,558.90 12,973.40
Gross Margin %
Consensus Estimate 65.57 65.18 65.16 65.07 64.43 65.29 65.45 66.25 66.45 64.35 67.26 67.54 67.5 67.36 67.15
Comparable Actual 65.8 64.7 65.5 64.7 64.8 65.3 65.3 66.6 66.2 64.5
Gross Margin Surprise % 0.4 -0.7 0.5 -0.5 0.6 0.1 -0.2 0.6 -0.3 0.2
GAAP Actual 65.8 64.7 65.5 64.7 64.8 65.3 65.3 66.6 66.2 64.5
Adjusted Actual 65.8 64.7 65.5 64.7 64.8 65.3 65.3 66.6 66.2 64.5
Pretax Income (Loss)
Consensus Estimate 4,085.90 4,734.30 4,875.40 4,565.30 4,470.20 5,609.30 7,087.60 8,774.80 9,417.20 5,937.70 12,759.00 14,265.80 15,837.80 16,464.20 17,846.60
Comparable Actual 4,263.50 4,644.30 4,835.70 6,754.70 4,336.40 5,301.90 6,953.50 8,396.70 9,399.50 6,549.40
Pretax Income (Loss) Surprise % 4.3 -1.9 -0.8 48 -3 -5.5 -1.9 -4.3 -0.2 10.3
GAAP Actual 4,263.50 4,644.30 4,840.00 6,754.70 4,336.40 5,395.30 7,058.60 8,396.70 9,399.50 6,549.40
Adjusted Actual 4,338.20 4,673.50 4,895.20 4,333.60 4,403.20 5,478.10 7,186.60 8,509.90 9,611.80 7,014.60
Net Income
Consensus Estimate 2,557.30 2,945.80 2,977.40 2,641.30 2,737.50 3,441.30 4,384.70 5,775.90 6,255.20 3,808.40 8,617.10 9,723.80 10,676.20 11,129.10 11,791.00
Comparable Actual 2,660.40 2,777.70 2,917.60 4,553.70 2,595.30 3,261.30 4,495.10 5,622.60 6,291.20 4,181.90
Net Income Surprise % 4 -5.7 -2 72.4 -5.2 -5.2 2.5 -2.7 0.6 9.8
GAAP Actual 2,660.40 2,777.70 2,917.60 4,553.70 2,595.30 3,330.90 4,702.00 5,622.60 6,291.20 4,181.90
Adjusted Actual 2,721.30 2,803.50 2,970.50 2,995.60 2,667.90 3,412.40 4,801.20 5,727.30 6,437.10 4,498.10
Source: Bloomberg Right click to show data transparency (not supported for all values)
Enterprise Value
LVMH Moet Hennessy Louis Vuitton SE (MC FP) - Enterprise Value
In Millions of GBP except Per Share FY 2011 FY 2012 FY 2013 FY 2014 FY 2015 FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 Current FY 2021 Est FY 2022 Est FY 2023 Est FY 2024 Est FY 2025 Est
12 Months Ending 12/31/2011 12/31/2012 12/31/2013 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 08/19/2021 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Market Capitalization 45,543.20 56,388.60 55,230.30 51,542.90 53,729.40 77,804.40 109,675.10 116,664.90 176,620.20 230,547.90 264,926.90
- Cash & Equivalents 7,044.50 6,806.50 8,720.70 3,823.90 3,357.70 3,347.40 3,780.70 4,740.40 5,423.60 18,551.10 7,470.00
+ Preferred Equity 0 0 0 0 0 0 0 0 0 0 0
+ Minority Interest 886.6 880.8 855.7 963 1,076.70 1,290.10 1,251.60 1,495.10 1,506.20 1,269.00 1,237.30
+ Total Debt 6,071.80 5,534.90 7,344.00 7,178.00 6,106.30 6,304.30 10,290.30 9,912.00 21,383.60 33,610.50 33,083.60
Enterprise Value 45,457.20 55,997.80 54,709.20 55,859.90 57,554.70 82,051.30 117,436.40 123,331.60 194,086.40 246,876.20 291,918.40
Total Capital 25,719.40 26,260.70 30,572.90 25,041.80 25,132.50 30,139.00 37,293.60 40,421.60 53,865.00 68,383.30
Total Debt/Total Capital 23.61 21.08 24.02 28.66 24.3 20.92 27.59 24.52 39.7 49.15
Total Debt/EV 0.13 0.1 0.13 0.13 0.11 0.08 0.09 0.08 0.11 0.14 0.11
EV/Sales 2.3 2.45 2.27 2.35 2.19 2.55 3.1 2.93 4.27 6.17 6.2 5.63 5.06 4.68 4.47 4.19
EV/EBITDA 8.84 9.79 8.94 9.81 9.21 10.62 12.59 11.29 14.02 19.6 17.05 17.5 15.71 14.19 15.19 13.65
EV/EBIT 10.55 12.01 11.1 13.23 12.2 13.92 16.28 13.93 20.39 34.4 24.14 22.36 19.84 17.82 16.87 15.85
EV/Cash Flow to Firm 13.46 16.07 13.47 15.05 13.66 15.15 18.58 15.91 19.15 24.71 18.94
EV/Free Cash Flow to Firm 23.74 25.77 19.92 22.14 19.64 22.93 25.31 22.79 26.42 31.77 21.19
Diluted Market Cap 44,997.30 56,640.60 55,541.10 51,748.40 53,953.40 78,209.10 109,947.50 116,902.50 176,685.80 230,691.60 264,545.20
Diluted Enterprise Value 44,911.30 56,249.80 55,020.00 56,065.50 57,778.70 82,456.10 117,708.90 123,569.20 194,152.00 247,020.00 291,316.40
EV per Share 91.25 112 109.33 111.31 114.47 163.44 233.58 245.24 385.36 489.94
Reference Items
Trailing 12 Month Values for Ratios
IFRS 16/ASC 842 Adoption No No No No No No No No Yes Yes Yes
Sales 20,535.60 22,798.10 24,638.10 24,701.70 25,905.10 30,802.40 37,366.70 41,435.60 47,085.10 39,711.80 48,664.60 51,871.60 57,738.10 62,383.70 65,378.30 69,686.30
EBITDA 5,340.70 5,709.50 6,246.10 5,910.60 6,158.10 7,409.00 9,195.30 10,756.70 14,346.60 12,508.30 16,568.80 18,452.20 20,433.90 19,158.90 21,317.50
EBIT 4,473.60 4,655.70 5,027.60 4,382.70 4,646.60 5,653.40 7,113.00 8,719.70 9,865.30 7,127.50 13,054.80 14,710.30 16,380.70 17,302.20 18,413.40
Cash Flow To Firm 3,506.70 3,478.50 4,144.20 3,854.60 4,149.30 5,192.60 6,230.40 7,633.50 10,502.80 9,921.30
Free Cash Flow To Firm 1,988.60 2,169.90 2,801.70 2,619.40 2,886.10 3,431.30 4,574.90 5,329.30 7,613.00 7,717.40
Source: Bloomberg Right click to show data transparency (not supported for all values)
EV EX Operating Lease
LVMH Moet Hennessy Louis Vuitton SE (MC FP) - EV Ex Operating Leases
In Millions of GBP except Per Share FY 2011 FY 2012 FY 2013 FY 2014 FY 2015 FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 Current FY 2021 Est FY 2022 Est FY 2023 Est FY 2024 Est FY 2025 Est
12 Months Ending 12/31/2011 12/31/2012 12/31/2013 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 08/19/2021 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Market Capitalization 45,543.20 56,388.60 55,230.30 51,542.90 53,729.40 77,804.40 109,675.10 116,664.90 176,620.20 230,547.90 264,926.90
- Cash & Equivalents 7,044.50 6,806.50 8,720.70 3,823.90 3,357.70 3,347.40 3,780.70 4,740.40 5,423.60 18,551.10 7,470.00
+ Preferred Equity 0 0 0 0 0 0 0 0 0 0 0
+ Minority Interest 886.6 880.8 855.7 963 1,076.70 …
CATEGORIES
Economics
Nursing
Applied Sciences
Psychology
Science
Management
Computer Science
Human Resource Management
Accounting
Information Systems
English
Anatomy
Operations Management
Sociology
Literature
Education
Business & Finance
Marketing
Engineering
Statistics
Biology
Political Science
Reading
History
Financial markets
Philosophy
Mathematics
Law
Criminal
Architecture and Design
Government
Social Science
World history
Chemistry
Humanities
Business Finance
Writing
Programming
Telecommunications Engineering
Geography
Physics
Spanish
ach
e. Embedded Entrepreneurship
f. Three Social Entrepreneurship Models
g. Social-Founder Identity
h. Micros-enterprise Development
Outcomes
Subset 2. Indigenous Entrepreneurship Approaches (Outside of Canada)
a. Indigenous Australian Entrepreneurs Exami
Calculus
(people influence of
others) processes that you perceived occurs in this specific Institution Select one of the forms of stratification highlighted (focus on inter the intersectionalities
of these three) to reflect and analyze the potential ways these (
American history
Pharmacology
Ancient history
. Also
Numerical analysis
Environmental science
Electrical Engineering
Precalculus
Physiology
Civil Engineering
Electronic Engineering
ness Horizons
Algebra
Geology
Physical chemistry
nt
When considering both O
lassrooms
Civil
Probability
ions
Identify a specific consumer product that you or your family have used for quite some time. This might be a branded smartphone (if you have used several versions over the years)
or the court to consider in its deliberations. Locard’s exchange principle argues that during the commission of a crime
Chemical Engineering
Ecology
aragraphs (meaning 25 sentences or more). Your assignment may be more than 5 paragraphs but not less.
INSTRUCTIONS:
To access the FNU Online Library for journals and articles you can go the FNU library link here:
https://www.fnu.edu/library/
In order to
n that draws upon the theoretical reading to explain and contextualize the design choices. Be sure to directly quote or paraphrase the reading
ce to the vaccine. Your campaign must educate and inform the audience on the benefits but also create for safe and open dialogue. A key metric of your campaign will be the direct increase in numbers.
Key outcomes: The approach that you take must be clear
Mechanical Engineering
Organic chemistry
Geometry
nment
Topic
You will need to pick one topic for your project (5 pts)
Literature search
You will need to perform a literature search for your topic
Geophysics
you been involved with a company doing a redesign of business processes
Communication on Customer Relations. Discuss how two-way communication on social media channels impacts businesses both positively and negatively. Provide any personal examples from your experience
od pressure and hypertension via a community-wide intervention that targets the problem across the lifespan (i.e. includes all ages).
Develop a community-wide intervention to reduce elevated blood pressure and hypertension in the State of Alabama that in
in body of the report
Conclusions
References (8 References Minimum)
*** Words count = 2000 words.
*** In-Text Citations and References using Harvard style.
*** In Task section I’ve chose (Economic issues in overseas contracting)"
Electromagnetism
w or quality improvement; it was just all part of good nursing care. The goal for quality improvement is to monitor patient outcomes using statistics for comparison to standards of care for different diseases
e a 1 to 2 slide Microsoft PowerPoint presentation on the different models of case management. Include speaker notes... .....Describe three different models of case management.
visual representations of information. They can include numbers
SSAY
ame workbook for all 3 milestones. You do not need to download a new copy for Milestones 2 or 3. When you submit Milestone 3
pages):
Provide a description of an existing intervention in Canada
making the appropriate buying decisions in an ethical and professional manner.
Topic: Purchasing and Technology
You read about blockchain ledger technology. Now do some additional research out on the Internet and share your URL with the rest of the class
be aware of which features their competitors are opting to include so the product development teams can design similar or enhanced features to attract more of the market. The more unique
low (The Top Health Industry Trends to Watch in 2015) to assist you with this discussion.
https://youtu.be/fRym_jyuBc0
Next year the $2.8 trillion U.S. healthcare industry will finally begin to look and feel more like the rest of the business wo
evidence-based primary care curriculum. Throughout your nurse practitioner program
Vignette
Understanding Gender Fluidity
Providing Inclusive Quality Care
Affirming Clinical Encounters
Conclusion
References
Nurse Practitioner Knowledge
Mechanics
and word limit is unit as a guide only.
The assessment may be re-attempted on two further occasions (maximum three attempts in total). All assessments must be resubmitted 3 days within receiving your unsatisfactory grade. You must clearly indicate “Re-su
Trigonometry
Article writing
Other
5. June 29
After the components sending to the manufacturing house
1. In 1972 the Furman v. Georgia case resulted in a decision that would put action into motion. Furman was originally sentenced to death because of a murder he committed in Georgia but the court debated whether or not this was a violation of his 8th amend
One of the first conflicts that would need to be investigated would be whether the human service professional followed the responsibility to client ethical standard. While developing a relationship with client it is important to clarify that if danger or
Ethical behavior is a critical topic in the workplace because the impact of it can make or break a business
No matter which type of health care organization
With a direct sale
During the pandemic
Computers are being used to monitor the spread of outbreaks in different areas of the world and with this record
3. Furman v. Georgia is a U.S Supreme Court case that resolves around the Eighth Amendments ban on cruel and unsual punishment in death penalty cases. The Furman v. Georgia case was based on Furman being convicted of murder in Georgia. Furman was caught i
One major ethical conflict that may arise in my investigation is the Responsibility to Client in both Standard 3 and Standard 4 of the Ethical Standards for Human Service Professionals (2015). Making sure we do not disclose information without consent ev
4. Identify two examples of real world problems that you have observed in your personal
Summary & Evaluation: Reference & 188. Academic Search Ultimate
Ethics
We can mention at least one example of how the violation of ethical standards can be prevented. Many organizations promote ethical self-regulation by creating moral codes to help direct their business activities
*DDB is used for the first three years
For example
The inbound logistics for William Instrument refer to purchase components from various electronic firms. During the purchase process William need to consider the quality and price of the components. In this case
4. A U.S. Supreme Court case known as Furman v. Georgia (1972) is a landmark case that involved Eighth Amendment’s ban of unusual and cruel punishment in death penalty cases (Furman v. Georgia (1972)
With covid coming into place
In my opinion
with
Not necessarily all home buyers are the same! When you choose to work with we buy ugly houses Baltimore & nationwide USA
The ability to view ourselves from an unbiased perspective allows us to critically assess our personal strengths and weaknesses. This is an important step in the process of finding the right resources for our personal learning style. Ego and pride can be
· By Day 1 of this week
While you must form your answers to the questions below from our assigned reading material
CliftonLarsonAllen LLP (2013)
5 The family dynamic is awkward at first since the most outgoing and straight forward person in the family in Linda
Urien
The most important benefit of my statistical analysis would be the accuracy with which I interpret the data. The greatest obstacle
From a similar but larger point of view
4 In order to get the entire family to come back for another session I would suggest coming in on a day the restaurant is not open
When seeking to identify a patient’s health condition
After viewing the you tube videos on prayer
Your paper must be at least two pages in length (not counting the title and reference pages)
The word assimilate is negative to me. I believe everyone should learn about a country that they are going to live in. It doesnt mean that they have to believe that everything in America is better than where they came from. It means that they care enough
Data collection
Single Subject Chris is a social worker in a geriatric case management program located in a midsize Northeastern town. She has an MSW and is part of a team of case managers that likes to continuously improve on its practice. The team is currently using an
I would start off with Linda on repeating her options for the child and going over what she is feeling with each option. I would want to find out what she is afraid of. I would avoid asking her any “why” questions because I want her to be in the here an
Summarize the advantages and disadvantages of using an Internet site as means of collecting data for psychological research (Comp 2.1) 25.0\% Summarization of the advantages and disadvantages of using an Internet site as means of collecting data for psych
Identify the type of research used in a chosen study
Compose a 1
Optics
effect relationship becomes more difficult—as the researcher cannot enact total control of another person even in an experimental environment. Social workers serve clients in highly complex real-world environments. Clients often implement recommended inte
I think knowing more about you will allow you to be able to choose the right resources
Be 4 pages in length
soft MB-920 dumps review and documentation and high-quality listing pdf MB-920 braindumps also recommended and approved by Microsoft experts. The practical test
g
One thing you will need to do in college is learn how to find and use references. References support your ideas. College-level work must be supported by research. You are expected to do that for this paper. You will research
Elaborate on any potential confounds or ethical concerns while participating in the psychological study 20.0\% Elaboration on any potential confounds or ethical concerns while participating in the psychological study is missing. Elaboration on any potenti
3 The first thing I would do in the family’s first session is develop a genogram of the family to get an idea of all the individuals who play a major role in Linda’s life. After establishing where each member is in relation to the family
A Health in All Policies approach
Note: The requirements outlined below correspond to the grading criteria in the scoring guide. At a minimum
Chen
Read Connecting Communities and Complexity: A Case Study in Creating the Conditions for Transformational Change
Read Reflections on Cultural Humility
Read A Basic Guide to ABCD Community Organizing
Use the bolded black section and sub-section titles below to organize your paper. For each section
Losinski forwarded the article on a priority basis to Mary Scott
Losinksi wanted details on use of the ED at CGH. He asked the administrative resident